Energenesis Biomedical Co Ltd
TWSE:6657
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Energenesis Biomedical Co Ltd
TWSE:6657
|
TW |
|
Ryman Hospitality Properties Inc
NYSE:RHP
|
US |
|
Prodia Widyahusada Tbk PT
IDX:PRDA
|
ID |
|
Jiangxi Copper Co Ltd
SSE:600362
|
CN |
|
Absa Group Ltd
OTC:AGRPF
|
ZA |
|
Schneider National Inc
NYSE:SNDR
|
US |
|
Zurich Insurance Group AG
F:ZFIN
|
CH |
|
Allianz SE
SIX:ALV
|
DE |
|
A
|
Amtech Systems Inc
SWB:AS3
|
US |
|
Nien Made Enterprise Co Ltd
TWSE:8464
|
TW |
|
Wayfair Inc
NYSE:W
|
US |
|
Teck Resources Ltd
NYSE:TECK
|
CA |
|
C
|
Crown Castle International Corp
F:8CW
|
US |
|
C
|
Community Health Systems Inc
XMUN:CG5
|
US |
|
Koninklijke Ahold Delhaize NV
AEX:AD
|
NL |
|
Dentsu Group Inc
OTC:DNTUY
|
JP |
|
A
|
African Rainbow Minerals Ltd
SWB:EB9
|
ZA |
|
D
|
Dicera Holdings JSC
VN:DC4
|
VN |
Bankruptcy Probability
Energenesis Biomedical Co Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Energenesis Biomedical Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TW |
E
|
Energenesis Biomedical Co Ltd
TWSE:6657
|
2.9B TWD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
462.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
228B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
185B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
132.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
76.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
52.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
59.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
85.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
44B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Energenesis Biomedical Co Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Energenesis Biomedical Co Ltd has total debt of 6.9m TWD. This includes both short-term (0 TWD) and long-term (6.9m TWD) debt.
You can find a full breakdown on its Balance Sheet.